# A Clinical Trial of PRAX-944 in Participants With Essential Tremor

> **NCT05021978** · PHASE2 · COMPLETED · sponsor: **Praxis Precision Medicines** · enrollment: 24 (actual)

## Conditions studied

- Essential Tremor

## Interventions

- **DRUG:** Part A: 20 and 40 mg PRAX-944
- **DRUG:** Part B: 120 mg PRAX-944
- **DRUG:** Part B: 120 mg PRAX-944 and Placebo

## Key facts

- **NCT ID:** NCT05021978
- **Lead sponsor:** Praxis Precision Medicines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-03
- **Primary completion:** 2022-03-24
- **Final completion:** 2022-03-24
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05021978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05021978, "A Clinical Trial of PRAX-944 in Participants With Essential Tremor". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05021978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*